Preclinical: As NAP interacts with both neuronal and glial tubulin to modulate microtubule assembly and clears amyloid and hyperphosphorylated tau in AD and SZ mouse models, as noted above, IN-NAP was also investigated in a transgenic mouse model of PD overexpressing α-synuclein. This evidence concerns the gene MAPT and Alzheimer disease.